Altamira Therapeutics Ltd. EARS
3.05 0.00 (+0.00%)
At closeJul 26, 2021, 12:00 AM EDT
3.00 Day range 3.09
52-week range unavailable
Analyst view
Price target (mean) —
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 1
- 2 months ago 1
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 59.10M | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 59.10M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | Roth Capital | Initiated | — | Buy |
| Nov 25, 2020 | Jefferies | Maintained | — | Buy |
| Nov 25, 2020 | Needham | Initiated | — | Buy |
| Nov 25, 2020 | Leerink Swann | Initiated | — | Outperform |
| Nov 25, 2020 | JMP Securities | Initiated | — | Market Perform |
| Nov 25, 2020 | Jefferies | Initiated | — | Buy |